Featured Publications
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Cluett J, Blazek O, Brown A, East C, Ferdinand K, Fisher N, Ford C, Griffin K, Mena-Hurtado C, Sarathy H, Vongpatanasin W, Townsend R, Disease O. Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension 2024, 81: e135-e148. PMID: 39101202, DOI: 10.1161/hyp.0000000000000240.Peer-Reviewed Original ResearchRenal denervationBlood pressureEfficacy of renal denervationUS Food and Drug AdministrationRandomized clinical studyRenal sympathetic nervesNovel treatment strategiesBlood pressure control ratesLonger-term efficacyIndividual patient responseLowering blood pressureFood and Drug AdministrationSpectrum of hypertensionTreatment of hypertensionControl blood pressureUncontrolled blood pressureMultiple ongoing studiesCatheter-based proceduresAmerican Heart AssociationHigh blood pressureTherapeutic optionsSafety profileCardiovascular morbidityControl rateHypertension specialists
2022
Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
Tran AT, Spertus JA, Mena‐Hurtado C, Jones PG, Aronow HD, Safley DM, Malik AO, Peri‐Okonny P, Shishehbor MH, Labrosciano C, Smolderen KG. Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease. Journal Of The American Heart Association 2022, 11: e022232. PMID: 35132874, PMCID: PMC9245831, DOI: 10.1161/jaha.121.022232.Peer-Reviewed Original ResearchConceptsPeripheral artery diseasePAD-specific health statusHealth statusPAD symptomsArtery diseaseHierarchical Cox regression modelsDisease-specific health statusLong-term mortality riskTime of diagnosisCox regression modelLong-term survivalPORTRAIT registryCardiovascular morbidityCause mortalityResults PatientsKaplan-MeierMortality riskUnadjusted modelsSummary scoresUS sitesPatientsMortalityBaselineSymptomsDisease